Cargando…
Harnessing gene expression to identify the genetic basis of drug resistance
The advent of cost-effective genotyping and sequencing methods have recently made it possible to ask questions that address the genetic basis of phenotypic diversity and how natural variants interact with the environment. We developed Camelot (CAusal Modelling with Expression Linkage for cOmplex Tra...
Autores principales: | , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2779083/ https://www.ncbi.nlm.nih.gov/pubmed/19888205 http://dx.doi.org/10.1038/msb.2009.69 |
_version_ | 1782174334658281472 |
---|---|
author | Chen, Bo-Juen Causton, Helen C Mancenido, Denesy Goddard, Noel L Perlstein, Ethan O Pe'er, Dana |
author_facet | Chen, Bo-Juen Causton, Helen C Mancenido, Denesy Goddard, Noel L Perlstein, Ethan O Pe'er, Dana |
author_sort | Chen, Bo-Juen |
collection | PubMed |
description | The advent of cost-effective genotyping and sequencing methods have recently made it possible to ask questions that address the genetic basis of phenotypic diversity and how natural variants interact with the environment. We developed Camelot (CAusal Modelling with Expression Linkage for cOmplex Traits), a statistical method that integrates genotype, gene expression and phenotype data to automatically build models that both predict complex quantitative phenotypes and identify genes that actively influence these traits. Camelot integrates genotype and gene expression data, both generated under a reference condition, to predict the response to entirely different conditions. We systematically applied our algorithm to data generated from a collection of yeast segregants, using genotype and gene expression data generated under drug-free conditions to predict the response to 94 drugs and experimentally confirmed 14 novel gene–drug interactions. Our approach is robust, applicable to other phenotypes and species, and has potential for applications in personalized medicine, for example, in predicting how an individual will respond to a previously unseen drug. |
format | Text |
id | pubmed-2779083 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2009 |
publisher | Nature Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-27790832009-11-20 Harnessing gene expression to identify the genetic basis of drug resistance Chen, Bo-Juen Causton, Helen C Mancenido, Denesy Goddard, Noel L Perlstein, Ethan O Pe'er, Dana Mol Syst Biol Article The advent of cost-effective genotyping and sequencing methods have recently made it possible to ask questions that address the genetic basis of phenotypic diversity and how natural variants interact with the environment. We developed Camelot (CAusal Modelling with Expression Linkage for cOmplex Traits), a statistical method that integrates genotype, gene expression and phenotype data to automatically build models that both predict complex quantitative phenotypes and identify genes that actively influence these traits. Camelot integrates genotype and gene expression data, both generated under a reference condition, to predict the response to entirely different conditions. We systematically applied our algorithm to data generated from a collection of yeast segregants, using genotype and gene expression data generated under drug-free conditions to predict the response to 94 drugs and experimentally confirmed 14 novel gene–drug interactions. Our approach is robust, applicable to other phenotypes and species, and has potential for applications in personalized medicine, for example, in predicting how an individual will respond to a previously unseen drug. Nature Publishing Group 2009-10-13 /pmc/articles/PMC2779083/ /pubmed/19888205 http://dx.doi.org/10.1038/msb.2009.69 Text en Copyright © 2009, EMBO and Nature Publishing Group http://creativecommons.org/licenses/by-nc-sa/3.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution Licence, which permits distribution and reproduction in any medium, provided the original author and source are credited. Creation of derivative works is permitted but the resulting work may be distributed only under the same or similar licence to this one. This licence does not permit commercial exploitation without specific permission. |
spellingShingle | Article Chen, Bo-Juen Causton, Helen C Mancenido, Denesy Goddard, Noel L Perlstein, Ethan O Pe'er, Dana Harnessing gene expression to identify the genetic basis of drug resistance |
title | Harnessing gene expression to identify the genetic basis of drug resistance |
title_full | Harnessing gene expression to identify the genetic basis of drug resistance |
title_fullStr | Harnessing gene expression to identify the genetic basis of drug resistance |
title_full_unstemmed | Harnessing gene expression to identify the genetic basis of drug resistance |
title_short | Harnessing gene expression to identify the genetic basis of drug resistance |
title_sort | harnessing gene expression to identify the genetic basis of drug resistance |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2779083/ https://www.ncbi.nlm.nih.gov/pubmed/19888205 http://dx.doi.org/10.1038/msb.2009.69 |
work_keys_str_mv | AT chenbojuen harnessinggeneexpressiontoidentifythegeneticbasisofdrugresistance AT caustonhelenc harnessinggeneexpressiontoidentifythegeneticbasisofdrugresistance AT mancenidodenesy harnessinggeneexpressiontoidentifythegeneticbasisofdrugresistance AT goddardnoell harnessinggeneexpressiontoidentifythegeneticbasisofdrugresistance AT perlsteinethano harnessinggeneexpressiontoidentifythegeneticbasisofdrugresistance AT peerdana harnessinggeneexpressiontoidentifythegeneticbasisofdrugresistance |